GlassScriptPhysician profile
David J Dimarco
NPI 1912104811
$3,401.26
in general payments reported to CMS, 2019-2025
24 companies · $533 in 2025
The $533 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $116 · 2021: $96.54 · 2022: $614 · 2023: $614 · 2024: $1,017 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,163.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $647.36 | 2022-2025 | Miebo, Xiidra, Ultra Multifocal Toric |
| Johnson & Johnson Vision Care, INC. | $445.03 | 2019-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $371.01 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $350.20 | 2019-2025 | Cequa |
| Abbvie INC. | $325.08 | 2022-2025 | Lumigan, Alphagan P |
| Oyster Point Pharma, INC. | $253.29 | 2022-2024 | Tyrvaya, Ryzumvi |
| Alcon Vision LLC | $214.00 | 2019-2025 | Rocklatan, Tryptyr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $128.80 | 2019-2021 | |
| Allergan, INC. | $73.94 | 2019-2021 | |
| Rxsight INC | $66.17 | 2023-2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Kala Pharmaceuticals, INC. | $65.68 | 2021-2022 | |
| Thea Pharma INC. | $62.69 | 2024-2025 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $53.14 | 2022 | |
| Harrow Eye, LLC | $48.39 | 2024 | Vevye |
| Horizon Therapeutics Plc | $43.52 | 2022-2023 | Tepezza |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $43.10 | 2023-2024 | Misight Contact Lens, Myday Contact Lens |
| Eyevance Pharmaceuticals LLC | $41.43 | 2019-2023 | Flarex |
| Glaukos Corporation | $36.27 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Ani Pharmaceuticals, INC. | $29.65 | 2025 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $27.32 | 2023 | Acthar |
| Dompe US, INC. | $21.77 | 2024 | Oxervate |
| New World Medical,INC. | $21.37 | 2023 | |
| Aerie Pharmaceuticals, INC. | $16.13 | 2019 | |
| Mallinckrodt Enterprises LLC | $15.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dimarco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.